These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27838080)

  • 61. An organ-preserving approach to muscle-invading transitional cell cancer of the bladder.
    Brown AL; Zietman AL; Shipley WU; Kaufman DS
    Hematol Oncol Clin North Am; 2001 Apr; 15(2):345-58, vii. PubMed ID: 11370497
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Yolk sac tumor differentiation in urothelial carcinoma of the urinary bladder: a case report and differential diagnosis.
    Espejo-Herrera N; Condom-Mundó E
    Diagn Pathol; 2020 Jun; 15(1):68. PubMed ID: 32493368
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
    Xu H; Genega EM; Zhuang L; Zhou M
    Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
    Bigongiari LR; Amis ES; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():697-702. PubMed ID: 11037487
    [No Abstract]   [Full Text] [Related]  

  • 66. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Systematic histologic urinary bladder mapping in primary urinary bladder cancers].
    Theuring F; Theuring U
    Pathologe; 1990 May; 11(3):148-53. PubMed ID: 2374761
    [No Abstract]   [Full Text] [Related]  

  • 68. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance.
    Azémar MD; Comperat E; Richard F; Cussenot O; Rouprêt M
    Urol Oncol; 2011; 29(2):130-6. PubMed ID: 19762256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic accuracy of preoperative urinary smear test in patients with bladder urothelial carcinoma in a high-volume center.
    Restrepo-Gonzalez JA; Garcia-Perdomo HA; Varela R
    Arch Esp Urol; 2014 Apr; 67(3):243-8. PubMed ID: 24840589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bladder cancer: natural history, tumor markers, and early detection strategies.
    Foresman WH; Messing EM
    Semin Surg Oncol; 1997; 13(5):299-306. PubMed ID: 9259085
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma.
    Rausch S; Lotan Y; Youssef RF
    Urol Oncol; 2014 Jan; 32(1):32.e11-6. PubMed ID: 23433891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports.
    Neşe N; Kandiloğlu AR; Atesçi YZ
    Int J Urol; 2007 Apr; 14(4):365-7. PubMed ID: 17470174
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytologic diagnosis of occult and "in-situ" carcinoma of the urinary system.
    Allegra SR; Fanning JP; Streker JF; Corvese NM
    Acta Cytol; 1966; 10(5):340-9. PubMed ID: 5230228
    [No Abstract]   [Full Text] [Related]  

  • 74. [Invasiveness and metastases of bladder cancer].
    Samsonov VA
    Vopr Onkol; 1985; 31(6):64-8. PubMed ID: 3161241
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Preneoplastic lesions and precursors of urothelial cancer].
    Knüchel-Clarke R; Gaisa NT
    Pathologe; 2016 Feb; 37(1):33-9. PubMed ID: 26811248
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder.
    Tong C; Daskalakis N; Edwards DC; Cahn DB; Belkoff L; Geynisman DM
    Urology; 2017 Sep; 107():23-25. PubMed ID: 28373110
    [No Abstract]   [Full Text] [Related]  

  • 77. Elevation of hyaluronidase-1 and soluble intercellular adhesion molecule-1 helps select bladder cancer patients at risk of invasion.
    Aboughalia AH
    Arch Med Res; 2006 Jan; 37(1):109-16. PubMed ID: 16314195
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature].
    Guo Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):213-5, 254. PubMed ID: 1327448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.